Test to skip breast surgery after chemo
Part of Cancer, Skin clinical trials.
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have triple-negative or HER2-positive breast cancer that has not spread to lymph nodes
- You have a single tumor and no cancer elsewhere in your body
- You have finished at least 12 weeks of chemo before surgery
- Your tumor was marked with a clip before chemo started
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
This trial aims to see if it is safe to skip surgery for women with triple-negative breast cancer who have no remaining cancer after chemotherapy and immunotherapy. If you qualify, you would avoid surgery but still receive close monitoring to ensure the cancer doesn't come back.
This trial tests if it's safe to skip a sentinel lymph node biopsy (a procedure to check if cancer has spread to the lymph nodes under your arm) when the breast tumor has completely disappeared after chemotherapy. If the trial finds it's safe, you could avoid this extra surgery and its side effects.
This trial tests whether it's safe to skip armpit surgery in people whose breast cancer has responded well to chemotherapy and whose lymph nodes appear cancer-free on ultrasound. It aims to reduce side effects like arm swelling while still controlling the cancer.
This study tests whether some patients with early-stage, hormone-positive breast cancer can safely skip chemotherapy and just use hormone therapy plus a CDK4/6 inhibitor pill after surgery. If you qualify, you may avoid chemo side effects while still reducing the chance of the cancer coming back.
This trial tests whether women who have a complete response to chemotherapy before breast-conserving surgery can safely skip a special radiation boost to the tumor bed. It aims to reduce unnecessary treatment side effects while maintaining good outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.